Literature DB >> 20449597

The neural and humoral pathways in remote limb ischemic preconditioning.

Shiang Y Lim1, Derek M Yellon, Derek J Hausenloy.   

Abstract

Remote ischaemic preconditioning (RIPC) is a therapeutic intervention that has been demonstrated to reduce myocardial injury in the clinical setting. However, the underlying cardioprotective mechanisms remain unclear. We hypothesised that RIPC utilises both humoral and neural pathways to convey the cardioprotective signal from the preconditioned remote organ to the heart. C57BL/6 mice were anaesthetised and subjected to in vivo 30 min coronary artery ischaemia followed by 120 min of myocardial reperfusion, at the end of which myocardial infarct size was measured and expressed as a percentage of the risk zone. RIPC was induced by 3 cycles of 5 min left femoral artery occlusion interspersed with 5 min reperfusion before prolonged myocardial ischaemia with or without femoral vein occlusion (humoral pathway), femoral nerve resection and/or sciatic nerve resection (neural pathway). RIPC resulted in a smaller myocardial infarct size when compared to control. However, occluding the femoral vein completely abolished the infarct-limiting effect of RIPC. Similarly, combined femoral and sciatic nerve resection also abolished the cardioprotective effect of RIPC. Interestingly, femoral nerve or sciatic nerve resection alone only partially abolished the infarct-limiting effect of RIPC. In conclusion, remote limb ischaemic preconditioning reduced myocardial infarct size in the mice in a manner which implicates both a neural and humoral pathway.

Entities:  

Mesh:

Year:  2010        PMID: 20449597     DOI: 10.1007/s00395-010-0099-y

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  80 in total

1.  Factors mediating remote preconditioning of trauma in the rat heart: central role of the cytochrome p450 epoxygenase pathway in mediating infarct size reduction.

Authors:  Garrett J Gross; Anna Hsu; Eric R Gross; John R Falck; Kasem Nithipatikom
Journal:  J Cardiovasc Pharmacol Ther       Date:  2012-03-09       Impact factor: 2.457

Review 2.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

Review 3.  Remote ischaemic conditioning-therapeutic opportunities in renal medicine.

Authors:  Lisa E Crowley; Christopher W McIntyre
Journal:  Nat Rev Nephrol       Date:  2013-11-05       Impact factor: 28.314

Review 4.  Ischaemic conditioning: pitfalls on the path to clinical translation.

Authors:  Karin Przyklenk
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 5.  Cardioprotection during cardiac surgery.

Authors:  Derek J Hausenloy; Edney Boston-Griffiths; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2012-03-22       Impact factor: 10.787

6.  Remote Limb Ischemic Conditioning at Two Cuff Inflation Pressures Yields Learning Enhancements in Healthy Adults.

Authors:  Kendra M Cherry-Allen; Jeff M Gidday; Jin-Moo Lee; Tamara Hershey; Catherine E Lang
Journal:  J Mot Behav       Date:  2016-10-12       Impact factor: 1.328

Review 7.  Cardioprotection by remote ischemic conditioning and its signal transduction.

Authors:  Petra Kleinbongard; Andreas Skyschally; Gerd Heusch
Journal:  Pflugers Arch       Date:  2016-12-07       Impact factor: 3.657

Review 8.  Concepts of hypoxic NO signaling in remote ischemic preconditioning.

Authors:  Matthias Totzeck; Ulrike Hendgen-Cotta; Tienush Rassaf
Journal:  World J Cardiol       Date:  2015-10-26

9.  Involvement of neuronal pathways in the protective effects of hindlimb perconditioning during renal ischemia.

Authors:  Zahra Sedaghat; Mehri Kadkhodaee; Behjat Seifi; Parisa Ahghari; Khalil Pourkhalili; Zahra Akbari; Mehdi Sadeghi
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

10.  Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency.

Authors:  Michalis Mastri; Zaeem Shah; Terence McLaughlin; Christopher J Greene; Leah Baum; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2012-07-25       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.